Lindenwold Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.81M Sell
5,250
-3,441
-40% -$1.04M 0.86% 38
2025
Q2
$2.71M Buy
8,691
+240
+3% +$91.7K 1.41% 20
2025
Q1
$4.43M Buy
8,451
+742
+10% +$379K 2.46% 9
2024
Q4
$3.9M Sell
7,709
-1,198
-13% -$681K 2.08% 13
2024
Q3
$5.21M Buy
8,907
+37
+0.4% +$20.9K 2.62% 8
2024
Q2
$4.52M Sell
8,870
-56
-0.6% -$27.4K 2.41% 8
2024
Q1
$4.42M Sell
8,926
-195
-2% -$99.1K 2.36% 9
2023
Q4
$4.8M Sell
9,121
-51
-0.6% -$27.2K 2.73% 7
2023
Q3
$4.62M Buy
9,172
+18
+0.2% +$8.86K 2.88% 7
2023
Q2
$4.4M Sell
9,154
-1,372
-13% -$671K 2.7% 7
2023
Q1
$4.97M Buy
10,526
+435
+4% +$210K 3.08% 4
2022
Q4
$5.35M Sell
10,091
-22
-0.2% -$11.7K 3.58% 4
2022
Q3
$5.11M Buy
10,113
+78
+0.8% +$41K 3.78% 4
2022
Q2
$5.15M Buy
10,035
+116
+1% +$58.3K 3.67% 4
2022
Q1
$5.06M Buy
9,919
+172
+2% +$83K 3.11% 4
2021
Q4
$4.89M Buy
+9,747
New +$4.41M 2.86% 4

Other funds holding UNH

Lindenwold Advisors's UNH Position: Q3 2025 in Review

Lindenwold Advisors reduced its UnitedHealth (UNH) stake by 40% in Q3 2025, selling an estimated $1.04M and leaving 5,250 shares worth $1.81M. The position accounts for 0.86% of the portfolio, ranked #38.

Lindenwold Advisors first reported a position in UNH in Q4 2021 and has held it in 16 quarters since. The position peaked at $5.35M in Q4 2022. 3,160 funds tracked by Wall St. Rank hold UNH as of Q3 2025.

  • Lindenwold Advisors held 5,250 shares of UnitedHealth worth $1.81M as of Q3 2025.
  • Lindenwold Advisors sold 3,441 UnitedHealth shares in Q3 2025, an estimated $1.04M.
  • UnitedHealth made up 0.86% of Lindenwold Advisors's portfolio in Q3 2025, its #38 holding.
  • Lindenwold Advisors first reported a position in UnitedHealth in Q4 2021 and has held it in 16 quarters since.
  • Lindenwold Advisors's UnitedHealth position peaked at $5.35M in Q4 2022.
  • 3,160 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2025.

Based on Lindenwold Advisors's 13F filing for Q3 2025, filed 16 Dec 2025.